FDA IDE validation of multiple myeloma MRD test by flow cytometry

Am J Hematol. 2024 Dec;99(12):2399-2401. doi: 10.1002/ajh.27484. Epub 2024 Sep 18.

Authors

Dragan Jevremovic¹, Min Shi¹, Pedro Horna¹, Gregory E Otteson¹, Michael M Timm¹, Shannon A Bennett², Linda B Baughn^{1

3}, Patricia T Greipp^{1

3}, Wilson I Gonsalves⁴, Prashant Kapoor⁴, Morie A Gertz⁴, Moritz Binder⁴, Francis K Buadi⁴, Angela Dispenzieri⁴, Taxiarchis Kourelis⁴, Eli Muchtar⁴, Jiehao Zhou⁵, S Vincent Rajkumar⁴, Shaji K Kumar⁴, Horatiu Olteanu¹

Affiliations

¹ Division of Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
² Quality Unit, Mayo Clinic, Rochester, Minnesota, USA.
³ Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁵ Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona, USA.

PMID: 39291868
DOI: 10.1002/ajh.27484

No abstract available

Publication types

Letter

Grants and funding